Anchor Investment Management, LLC Stoke Therapeutics, Inc. Transaction History

Anchor Investment Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jan 02, 2024	SELL	$30.53 - $41.09 $2,014 - $2,711	-66 Closed	0 $0
Q3 2020 Jan 02, 2024	BUY	$22.23 - $37.48 $1,467 - $2,473	66 New	66 $2.21 Million
Q2 2020 Jan 02, 2024	SELL	$20.26 - $29.73 $2,147 - $3,151	-106 Reduced 61.63%	66 $1.57 Million
Q4 2019 Jan 02, 2024	BUY	$20.01 - $30.79 $3,441 - $5,295	172 New	172 $4.87 Million

125

57.6M

9.3K

35.2K

Ticker STOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,419,300
Market Cap $395M
Description
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...

Get notified when there are updates to the investment portfolio of Anchor Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Anchor Investment Management, LLC with notifications on news.